Literature DB >> 17514462

[The German Health Interview and Examination Survey for Children and Adolescents (KiGGS): state of immunity against poliomyelitis in German children].

S Diedrich1, E Schreier.   

Abstract

One of the goals of the WHO is the worldwide eradication of poliomyelitis in the coming years. Europe was declared poliofree in 2002, but increasing migration may lead to a come-back of circulating polioviruses. A high level of population immunity protects against imported wild viruses from endemic areas. The first seroprevalence data since the switch from live to inactivated vaccine in Germany (OPV to IPV) are provided. A serum panel was tested (n=2,046) in order to study the serological status against poliomyelitis. The microneutralization test on RD cells was used. Overall, neutralizing antibodies against poliovirus types 1, 2 and 3 were detected in 97.4%, 97.6%, and 93.6% of samples, respectively. Of the test persons, 91.7% had antibodies against all three virus types. Only 26 children simultaneously lacked neutralizing antibodies for all three serotypes (1.3%). No significant correlation between gender, region (East/West)), migration status (with/without migration background) and antibody prevalence to polioviruses was found. The seroprevalence of antibodies against all three types of polioviruses indicates a very high level of population immunity in German children. It must be maintained through consequently performed vaccination programmes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17514462     DOI: 10.1007/s00103-007-0239-1

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  6 in total

1.  Immunization rates at the school entry in 2012.

Authors:  Martin Weigel; Roswitha Bruns; Kerstin Weitmann; Wolfgang Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2014-11-14       Impact factor: 5.594

2.  Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany.

Authors:  Holger F Rabenau; Matthias Richter; Hans Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2009-11-26       Impact factor: 3.402

3.  Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey.

Authors:  Jiawei Xu; Qing Wang; Shanshan Kuang; Rong Rong; Yuanyuan Zhang; Xiaojuan Fu; Wenge Tang
Journal:  Hum Vaccin Immunother       Date:  2021-03-24       Impact factor: 3.452

4.  Deficiency of immunity to poliovirus type 3: a lurking danger?

Authors:  Claudia Reinheimer; Imke Friedrichs; Holger F Rabenau; Hans W Doerr
Journal:  BMC Infect Dis       Date:  2012-01-26       Impact factor: 3.090

Review 5.  Is EU/EEA population protected from polio?

Authors:  Dre Nijsten; P Carrillo-Santisteve; A Miglietta; J Ruitenberg; P L Lopalco
Journal:  Hum Vaccin Immunother       Date:  2015-04-21       Impact factor: 3.452

6.  PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS.

Authors:  José Cassio de Moraes; Maria Josefa Penon Rujula; Marcelo Otsuka
Journal:  Rev Paul Pediatr       Date:  2021-02-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.